Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VN3O
|
|||
| Former ID |
DIB010531
|
|||
| Drug Name |
Lmprime P66
|
|||
| Indication | leukaemia [ICD-11: 2A60-2B33; ICD-9: 208.9] | Phase 3 | [1] | |
| Company |
Biothera
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01309126) Study of Imprime PGG in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.